Protara Therapeutics Inc's Comment on Supply Chain
The company utilizes contract development and manufacturing organizations (CDMOs) and suppliers for the production of its product candidates, including TARA-002. There is no guarantee that these manufacturers can meet FDA specifications or produce sufficient quantities for clinical trials or commercialization. Scaling up biologic manufacturing presents challenges, and CDMOs may lack the capabilities for scaling, production transfer, or capacity management. The use of biological and hazardous materials by CDMOs and suppliers involves risks such as injury, contamination, and regulatory compliance costs. The company does not maintain specific insurance coverage for exposure to biological or hazardous waste. Additionally, changes in manufacturing methods or formulation during development may result in delays, increased costs, altered clinical trial outcomes, and may require further FDA notification or approval, potentially delaying product approval.
Protara Therapeutics Inc's Comment on Supply Chain
The company utilizes contract development and manufacturing organizations (CDMOs) and suppliers for the production of its product candidates, including TARA-002. There is no guarantee that these manufacturers can meet FDA specifications or produce sufficient quantities for clinical trials or commercialization. Scaling up biologic manufacturing presents challenges, and CDMOs may lack the capabilities for scaling, production transfer, or capacity management. The use of biological and hazardous materials by CDMOs and suppliers involves risks such as injury, contamination, and regulatory compliance costs. The company does not maintain specific insurance coverage for exposure to biological or hazardous waste. Additionally, changes in manufacturing methods or formulation during development may result in delays, increased costs, altered clinical trial outcomes, and may require further FDA notification or approval, potentially delaying product approval.
Sources:
Protara Therapeutics Inc's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Protara Therapeutics Inc’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
